Role of Cytokine-Inducible SH2 Domain-Containing (CISH) Protein in the Regulation of Erythropoiesis

被引:2
|
作者
Maymand, Saeed [1 ]
Lakkavaram, Asha L. [1 ]
Naser, Wasan [1 ,2 ]
Rasighaemi, Parisa [1 ]
Dlugolenski, Daniel [1 ]
Liongue, Clifford [1 ,3 ]
Stambas, John [1 ,3 ]
de Koning-Ward, Tania F. [1 ,3 ]
Ward, Alister C. [1 ,3 ]
机构
[1] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia
[2] Univ Baghdad, Coll Sci, Baghdad, Iraq
[3] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic 3216, Australia
关键词
cytokine; CISH; EPO; SOCS; T-CELLS; STAT5; RECEPTOR; PROLIFERATION;
D O I
10.3390/biom13101510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine-inducible SH2 domain-containing (CISH) protein was the first member of the suppressor of cytokine signaling (SOCS) family of negative feedback regulators discovered, being identified in vitro as an inducible inhibitor of erythropoietin (EPO) signaling. However, understanding of the physiological role played by CISH in erythropoiesis has remained limited. To directly assess the function of CISH in this context, mice deficient in CISH were characterized with respect to developmental, steady-state, and EPO-induced erythropoiesis. CISH was strongly expressed in the fetal liver, but CISH knockout (KO) mice showed only minor disruption of primitive erythropoiesis. However, adults exhibited mild macrocytic anemia coincident with subtle perturbation particularly of bone marrow erythropoiesis, with EPO-induced erythropoiesis blunted in the bone marrow of KO mice but enhanced in the spleen. Cish was expressed basally in the bone marrow with induction following EPO stimulation in bone marrow and spleen. Overall, this study indicates that CISH participates in the control of both basal and EPO-induced erythropoiesis in vivo.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Studies on the regulation of SH2 domain-containing inositol 5-phosphatase(SHIP) activity.
    Phee, H
    Jacob, A
    Coggeshall, KM
    FASEB JOURNAL, 2000, 14 (06): : A967 - A967
  • [22] Characterization of human SH2 domain-containing protein 4A (SH2D4A) in HeLa cells
    Tamborlin, Leticia
    Pereira, Karina Danielle
    Meneguello, Leticia
    Gomes de Proenca, Andre Ricardo
    Luchessi, Augusto Ducati
    FASEB JOURNAL, 2017, 31
  • [23] Involvement of a JAK/STAT pathway inhibitor: Cytokine inducible SH2 containing protein in breast cancer
    Borges, Sahra
    Moudilou, Elara
    Vouyovitch, Cecile
    Chiesa, Jean
    Lobie, Peter
    Mertani, Hichem
    Raccurt, Mireille
    HORMONAL CARCINOGENESIS V, 2008, 617 : 321 - 329
  • [24] GENE-EXPRESSION AND TARGETING OF AN ACTIN-BINDING AND SH2 DOMAIN-CONTAINING PROTEIN, TENSIN
    LO, SH
    YU, QC
    DUGGER, D
    DEGENSTEIN, L
    FUCHS, E
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 142 - 142
  • [25] SH2 DOMAIN-CONTAINING SIGNALING PROTEINS IN HUMAN BREAST-CANCER
    DALY, RJ
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 34 (01) : 85 - 92
  • [26] Differential effects of lipids on cellular activities of SH2 domain-containing Proteins
    Singaram, Indira
    Cho, Wonhwa
    FASEB JOURNAL, 2017, 31
  • [27] Increased growth hormone receptor (GHR) degradation due to over-expression of cytokine inducible SH2 domain-containing protein (CIS) as a cause of GH transduction defect (GHTD)
    Gil, Andrea Paola Rojas
    Kostopoulou, Eirini
    Karageorgou, Ioulia
    Kamzelas, Konstantinos
    Spiliotis, Bessie Eugenia
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (9-10): : 897 - 908
  • [28] Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1
    Dong, Q
    Siminovitch, KA
    Fialkow, L
    Fukushima, T
    Downey, GP
    JOURNAL OF IMMUNOLOGY, 1999, 162 (06): : 3220 - 3230
  • [29] Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc
    Stanley K Liu
    C Jane McGlade
    Oncogene, 1998, 17 : 3073 - 3082
  • [30] Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc
    Liu, SK
    McGlade, CJ
    ONCOGENE, 1998, 17 (24) : 3073 - 3082